3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Gastrointestinal
2
Breast
2
Thoracic
1
Gynecologic
1
Conditions
Colorectal Neoplasms
5
Breast Neoplasms
4
Prostatic Neoplasms
2
Endometrial Neoplasms
2
Colonic Neoplasms
2
Smoking Cessation
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Motor Activity
1
Melanoma
1
Lung Neoplasms
1
Gastrointestinal Neoplasms
1
Colorectal Cancer Screening
1
Behavior
1
Interventions
pembrolizumab
17
Surveys and Questionnaires
12
Specimen Handling
11
Docetaxel
11
Nivolumab
9
Interviews as Topic
9
Standard of Care
8
Gemcitabine
8
Early Intervention, Educational
8
olaparib
7
enzalutamide
7
Magnetic Resonance Spectroscopy
7
Psychiatric Rehabilitation
6
Paclitaxel
6
durvalumab
5
Trastuzumab
5
Radiotherapy
5
Ipilimumab
5
Carboplatin
5
Bevacizumab
5
pertuzumab
4
palbociclib
4
cabozantinib
4
atezolizumab
4
abiraterone
4
Therapeutics
4
Taxes
4
Oxaliplatin
4
Methods
4
Immunoglobulin G
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
Motivational Interviewing
×
Gastrointestinal
×
Clear all
NCT05162846
2026-03-09
MiGHT
University of Michigan Rogel Cancer Center
Phase NA
Completed
831 enrolled
NCT05354882
2023-05-09
DEFACTO2
Université Sorbonne Paris Nord
Phase NA
Unknown
150 enrolled